Laserfiche WebLink
Required DOT Drug Tests & Cutoffs <br />TYPE OF DRUG <br />INITIAL TEST <br />CONFIRMATORY TEST <br />CONFIRMATORY TEST <br />Initial Test Analyte <br />Cutoff Concentrations <br />Analyte <br />Cutoff Concentration <br />Marijuana metabolites THCA 10 <br />50 n /mL" <br />THCA <br />15 ng/ml- <br />Cocaine metabolite <br />150 ng/mL" <br />Benzoylecgonine <br />100 ng/ml- <br />Benzo lec onine <br />Opioids: <br />Codeine/Morphine <br />2000 ng/mL <br />Codeine <br />2000 ng/mL <br />Morphine <br />2000 ng/mL <br />Hydrocodone/Hydromorphone <br />300 ng/ml- <br />Hydrocodone <br />100 ng/mL <br />Hydromorphone <br />100 ng/ml- <br />Oxycodone/Oxymorphone <br />100 ng/ml- <br />Oxycodone <br />100 ng/mL <br />Oxymorphone <br />100 ng/ml- <br />6-Acet Imor hine <br />10 n /ml- <br />6-Acet Imor hine <br />10 n /mL ' <br />Phencyclidine <br />25 n /mL <br />Phenc clidine <br />25 n /mL <br />Amphetamine/Methamphetamine <br />500 ng/mL <br />Amphetamine <br />250ng/mL <br />Methamphetamine <br />250 ng/ml- <br />MDMA'2/MDA13 <br />500 ng/mL <br />MDMA <br />250 ng/ml- <br />MDA <br />250 n /ml- <br />Table 1 <br />9 For grouped analytes (i.e, two or more analytes Chat are in the same drug class and have the same initial test cutoff): <br />Lmnunoassay, The test must be calibrated with one analyte from the group identified as the target analyte. The cross -reactivity <br />of the immunoassay to the other analytes) within the group must be 80 percent or greater. If not, separate immunoassays must be <br />used for the analytes within the group. <br />Alternate technology: Either one analyte or all analytes from the group must be used for calibration, depending on the <br />technology. At least one analyte within the group must have a concentration equal to or greater than the initial test cutoff or, <br />alternatively, the sum of the analytes present (i.e,, equal to or greater than the laboratory's validated limit of quantification) must <br />be equal to or greater than the initial test cutoff. <br />10 An innnunoassay must be calibrated with the target analyte Delta-9-tetrahydroeannabinol-9-carboxylic acid (THCA) <br />Alternate technology (THCA and benzoyleegonine): When using alternate technology to test for THCA and Benzoylecgonine, <br />the screening and confirmatory test cutoff concentrations must be the same respectively (i.e., 15 ng/mL for THCA and 100 ug/mL <br />for Benzoyleegnine). <br />iz Metlrylenedioxymethamphetamine (MDMA) <br />Methylenedioxyamphetamine (MDA) <br />Premium Concrete Services, Inc.- PHMSA DRUGIALCOHOL PLAN 25 <br />C IJA riONHI C04f PLIANCE MA�WGEMENT SERVICE, I�IC_ (�ICMS)'20r 1 (upUale 2°217. The NGMS plan is <br />the subject of a registeretl copyriyM1t entl is p,olectetl by copy�igM1t 13,vs In Ilse 11 $. antl elsewhere. All +igl,�s <br />e.ervQd <br />